RU2016101718A3 - - Google Patents

Download PDF

Info

Publication number
RU2016101718A3
RU2016101718A3 RU2016101718A RU2016101718A RU2016101718A3 RU 2016101718 A3 RU2016101718 A3 RU 2016101718A3 RU 2016101718 A RU2016101718 A RU 2016101718A RU 2016101718 A RU2016101718 A RU 2016101718A RU 2016101718 A3 RU2016101718 A3 RU 2016101718A3
Authority
RU
Russia
Application number
RU2016101718A
Other versions
RU2016101718A (ru
RU2732440C2 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52141164&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2016101718(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of RU2016101718A publication Critical patent/RU2016101718A/ru
Publication of RU2016101718A3 publication Critical patent/RU2016101718A3/ru
Application granted granted Critical
Publication of RU2732440C2 publication Critical patent/RU2732440C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dermatology (AREA)
RU2016101718A 2013-06-24 2014-06-24 Пептиды и пептидомиметики для комбинированного применения и лечения в субпопуляциях пациентов с раковыми заболеваниями RU2732440C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361838777P 2013-06-24 2013-06-24
US61/838,777 2013-06-24
PCT/IB2014/001579 WO2014207556A1 (en) 2013-06-24 2014-06-24 Peptides and peptidomimetics in combination uses and treatments for cancer patient subpopulations

Publications (3)

Publication Number Publication Date
RU2016101718A RU2016101718A (ru) 2017-07-28
RU2016101718A3 true RU2016101718A3 (ru) 2018-03-01
RU2732440C2 RU2732440C2 (ru) 2020-09-16

Family

ID=52141164

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2016101718A RU2732440C2 (ru) 2013-06-24 2014-06-24 Пептиды и пептидомиметики для комбинированного применения и лечения в субпопуляциях пациентов с раковыми заболеваниями

Country Status (28)

Country Link
US (1) US9221872B2 (ru)
EP (1) EP3013351B1 (ru)
JP (1) JP6401255B2 (ru)
KR (1) KR102247493B1 (ru)
CN (1) CN105324121A (ru)
AU (1) AU2014300713B2 (ru)
BR (1) BR112015032542A2 (ru)
CA (1) CA2916136C (ru)
CL (1) CL2015003704A1 (ru)
CY (1) CY1122523T1 (ru)
DK (1) DK3013351T3 (ru)
ES (1) ES2765300T3 (ru)
HK (1) HK1219905A1 (ru)
HR (1) HRP20192264T1 (ru)
HU (1) HUE046873T2 (ru)
IL (1) IL243266B (ru)
LT (1) LT3013351T (ru)
MX (1) MX366341B (ru)
MY (1) MY182232A (ru)
PH (1) PH12015502855A1 (ru)
PL (1) PL3013351T3 (ru)
PT (1) PT3013351T (ru)
RS (1) RS60180B1 (ru)
RU (1) RU2732440C2 (ru)
SG (1) SG11201510490VA (ru)
SI (1) SI3013351T1 (ru)
WO (1) WO2014207556A1 (ru)
ZA (1) ZA201600089B (ru)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9273093B2 (en) 2012-10-11 2016-03-01 Protagonist Therapeutics, Inc. α4β7 peptide dimer antagonists
WO2014145561A2 (en) 2013-03-15 2014-09-18 Protagonist Therapeutics, Inc. Hepcidin analogues and uses therof
ES2890600T3 (es) 2014-05-16 2022-01-20 Protagonist Therapeutics Inc Péptidos de tioéter antagonistas de integrina alfa4beta7
KR102482790B1 (ko) 2014-07-17 2022-12-29 프로타고니스트 테라퓨틱스, 인코포레이티드 인터루킨-23 수용체의 경구용 펩티드 억제제 및 염증성 장 질환을 치료하기 위한 그의 용도
WO2016054445A1 (en) 2014-10-01 2016-04-07 Protagonist Therapeutics, Inc. Novel cyclic monomer and dimer peptides having integrin antagonist activity
US9809623B2 (en) 2014-10-01 2017-11-07 Protagonist Therapeutics, Inc. α4β7 peptide monomer and dimer antagonists
US10787490B2 (en) 2015-07-15 2020-09-29 Protaganist Therapeutics, Inc. Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
TWI805542B (zh) * 2015-10-23 2023-06-21 日商坎巴斯有限公司 用於癌症治療之肽及擬肽與ｔ細胞活化劑及／或查核點抑制劑之組合
US10149887B2 (en) * 2015-10-23 2018-12-11 Canbas Co., Ltd. Peptides and peptidomimetics in combination with t cell activating and/or checkpoint inhibiting agents for cancer treatment
WO2017117411A1 (en) 2015-12-30 2017-07-06 Protagonist Therapeutics, Inc. Analogues of hepcidin mimetics with improved in vivo half lives
CN109195618A (zh) 2016-03-23 2019-01-11 领导医疗有限公司 用于合成α4β7肽拮抗剂的方法
CA3026074A1 (en) 2016-06-01 2017-12-07 M3 Biotechnology, Inc. N-hexanoic-l-tyrosine-l-isoleucine-(6)-aminohexanoic amide compounds and their use to treat neurodegenerative diseases
EP3681900A4 (en) 2017-09-11 2021-09-08 Protagonist Therapeutics, Inc. OPIOID AGONIST PEPTIDES AND THEIR USES
WO2019157268A1 (en) 2018-02-08 2019-08-15 Protagonist Therapeutics, Inc. Conjugated hepcidin mimetics
CN114341161A (zh) 2019-07-10 2022-04-12 领导医疗有限公司 白细胞介素-23受体的肽抑制剂及其用于治疗炎症性疾病的用途
JOP20220169A1 (ar) 2020-01-15 2023-01-30 Janssen Biotech Inc مثبطات ببتيدية لمستقبلة انترلوكين-23 واستخدامها في معالجة الأمراض الالتهابية
WO2021146454A1 (en) 2020-01-15 2021-07-22 Janssen Biotech, Inc. Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
KR20230110570A (ko) 2020-11-20 2023-07-24 얀센 파마슈티카 엔.브이. 인터류킨-23 수용체의 펩티드 억제제의 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1483290T1 (sl) * 2002-01-17 2009-02-28 Takeda Pharmaceutical Peptidi in peptidomimetiki, ki imajo antiproliferacijsko aktivnost in/ali okrepijo sredstva ali obdelave, ki poškodujejo nukleinsko kislino
US7148349B2 (en) * 2002-10-31 2006-12-12 Metabasis Therapeutics, Inc. Cyclic phosphate diesters of 1,3-propane-1-aryl diols and their use in preparing prodrugs
US7125842B2 (en) * 2003-04-07 2006-10-24 Canbas Co. Ltd. Anti-fungal compounds and methods of use
CN1812805A (zh) * 2003-06-25 2006-08-02 坎巴斯有限公司 具有免疫调节活性、抗炎活性和抗病毒活性的肽和肽模仿物
US20100112089A1 (en) 2008-05-14 2010-05-06 Takeda Pharmaceutical Company Limited Peptide compound and use thereof

Also Published As

Publication number Publication date
AU2014300713A1 (en) 2016-01-21
AU2014300713B2 (en) 2019-02-14
SI3013351T1 (sl) 2020-03-31
HRP20192264T1 (hr) 2020-03-06
HK1219905A1 (zh) 2017-04-21
IL243266A0 (en) 2016-03-31
MX366341B (es) 2019-07-05
RU2016101718A (ru) 2017-07-28
ES2765300T3 (es) 2020-06-08
CY1122523T1 (el) 2021-01-27
HUE046873T2 (hu) 2020-03-30
EP3013351A4 (en) 2017-03-01
PL3013351T3 (pl) 2020-05-18
DK3013351T3 (da) 2020-01-27
BR112015032542A2 (pt) 2017-07-25
CN105324121A (zh) 2016-02-10
MX2015017609A (es) 2016-04-15
JP2016522245A (ja) 2016-07-28
WO2014207556A1 (en) 2014-12-31
ZA201600089B (en) 2020-02-26
LT3013351T (lt) 2020-01-10
NZ715285A (en) 2021-09-24
IL243266B (en) 2019-11-28
US20150056301A1 (en) 2015-02-26
KR102247493B1 (ko) 2021-04-30
PH12015502855B1 (en) 2016-04-04
RU2732440C2 (ru) 2020-09-16
JP6401255B2 (ja) 2018-10-10
KR20160021792A (ko) 2016-02-26
CA2916136A1 (en) 2014-12-31
PT3013351T (pt) 2020-01-17
EP3013351B1 (en) 2019-10-30
CA2916136C (en) 2022-10-18
EP3013351A1 (en) 2016-05-04
PH12015502855A1 (en) 2016-04-04
SG11201510490VA (en) 2016-01-28
US9221872B2 (en) 2015-12-29
RS60180B1 (sr) 2020-06-30
MY182232A (en) 2021-01-18
CL2015003704A1 (es) 2016-07-29

Similar Documents

Publication Publication Date Title
AP2016009275A0 (ru)
BR102016010778A2 (ru)
BR112015007533A2 (ru)
BR112014017733A2 (ru)
BR112014018502A2 (ru)
BR112014017739A2 (ru)
BR112014019326A2 (ru)
BR112014018516A2 (ru)
BR112014017855A2 (ru)
BR112014020341A2 (ru)
BR112014018480A2 (ru)
BR112014017765A2 (ru)
BR112014017669A2 (ru)
BR112014021878A2 (ru)
RU2016101718A3 (ru)
BR112014018468A2 (ru)
BR112014017901A2 (ru)
BR112014018207A2 (ru)
BR112014019204A2 (ru)
BR112014017722A2 (ru)
BR112015015948A2 (ru)
BR112014018578A2 (ru)
BR112014018483A2 (ru)
BR112014017794A2 (ru)
BR112014017653A2 (ru)